Who is at risk for immune checkpoint inhibitor-induced colitis among Korean patients?
作者信息
Kim Ji Hyun, Park Sung Chul
机构信息
Department of Internal Medicine, Kangwon National University College of Medicine, Chuncheon, Korea.
出版信息
Korean J Intern Med. 2025 Jan;40(1):3-4. doi: 10.3904/kjim.2024.417. Epub 2025 Jan 1.
Abstract
摘要
相似文献
1
Who is at risk for immune checkpoint inhibitor-induced colitis among Korean patients?韩国患者中哪些人有患免疫检查点抑制剂诱导的结肠炎的风险？
Korean J Intern Med. 2025 Jan;40(1):3-4. doi: 10.3904/kjim.2024.417. Epub 2025 Jan 1.
2
Incidence and risk factors of immune checkpoint inhibitor-induced colitis in Korean patients with cancer.韩国癌症患者中免疫检查点抑制剂诱发结肠炎的发病率及危险因素
Korean J Intern Med. 2025 Jan;40(1):49-56. doi: 10.3904/kjim.2024.135. Epub 2025 Jan 1.
3
Immune checkpoint inhibitor-related colitis in patients on immunotherapy for cancer.癌症免疫治疗患者的免疫检查点抑制剂相关性结肠炎。
Am J Clin Pathol. 2024 Jul 5;162(1):17-27. doi: 10.1093/ajcp/aqae002.
4
New strategies in the diagnosis and treatment of immune-checkpoint inhibitor-mediated colitis.免疫检查点抑制剂介导的结肠炎诊断与治疗新策略
World J Clin Cases. 2024 Feb 26;12(6):1050-1062. doi: 10.12998/wjcc.v12.i6.1050.
5
Immune Checkpoint Inhibitor-Induced Colitis: Diagnosis and Management.免疫检查点抑制剂诱导的结肠炎：诊断与管理
Target Oncol. 2017 Jun;12(3):301-308. doi: 10.1007/s11523-017-0495-4.
6
Immune checkpoint inhibitor treatment induces colitis with heavy infiltration of CD8 + T cells and an infiltration pattern that resembles ulcerative colitis.免疫检查点抑制剂治疗可引发结肠炎，大量浸润 CD8+T 细胞，浸润模式类似于溃疡性结肠炎。
Virchows Arch. 2021 Dec;479(6):1119-1129. doi: 10.1007/s00428-021-03170-x. Epub 2021 Aug 2.
7
Evaluation of the safety and immunological effects of Bacillus Calmette-Guérin in combination with checkpoint inhibitor therapy in a patient with neuroendocrine carcinoma: a case report.评价卡介苗联合检查点抑制剂治疗神经内分泌癌患者的安全性和免疫效果：病例报告。
J Med Case Rep. 2023 Sep 4;17(1):377. doi: 10.1186/s13256-023-04117-3.
8
Complete Recovery of Immune Checkpoint Inhibitor-induced Colitis by Diverting Loop Ileostomy.通过回肠造口术改变肠回路治疗免疫检查点抑制剂诱导的结肠炎的完全缓解。
J Immunother. 2020 May;43(4):145-148. doi: 10.1097/CJI.0000000000000309.
9
Systematic review and case series: flexible sigmoidoscopy identifies most cases of checkpoint inhibitor-induced colitis.系统评价和病例系列：乙状结肠镜检查可识别大多数免疫检查点抑制剂相关性结肠炎病例。
Aliment Pharmacol Ther. 2019 Jun;49(12):1474-1483. doi: 10.1111/apt.15263. Epub 2019 Apr 29.
10
Double Whammy: A Case Report of Immune Checkpoint Inhibitor Colitis and Concomitant Colitis in a Patient on Nivolumab.双重打击：一例接受纳武单抗治疗患者出现免疫检查点抑制剂相关性结肠炎合并并存性结肠炎的病例报告
ACG Case Rep J. 2024 Dec 27;12(1):e01569. doi: 10.14309/crj.0000000000001569. eCollection 2025 Jan.
本文引用的文献
1
Incidence and risk factors of immune checkpoint inhibitor-induced colitis in Korean patients with cancer.韩国癌症患者中免疫检查点抑制剂诱发结肠炎的发病率及危险因素
Korean J Intern Med. 2025 Jan;40(1):49-56. doi: 10.3904/kjim.2024.135. Epub 2025 Jan 1.
2
Endoscopic findings of immune checkpoint inhibitor-related gastrointestinal adverse events.免疫检查点抑制剂相关胃肠道不良事件的内镜检查结果
Clin Endosc. 2024 Nov;57(6):725-734. doi: 10.5946/ce.2024.003. Epub 2024 Aug 29.
3
Immune checkpoint Inhibitor-Induced diarrhea and Colitis: Incidence and Management. A systematic review and Meta-analysis.免疫检查点抑制剂相关腹泻和结肠炎：发病机制和管理。一项系统评价和荟萃分析。
Cancer Treat Rev. 2022 Sep;109:102440. doi: 10.1016/j.ctrv.2022.102440. Epub 2022 Jul 26.
4
A decade of immune-checkpoint inhibitors in cancer therapy.免疫检查点抑制剂在癌症治疗中的十年。
Nat Commun. 2020 Jul 30;11(1):3801. doi: 10.1038/s41467-020-17670-y.
5
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance.从免疫相关不良事件的真实世界研究中吸取的经验教训：药物警戒的临床视角。
Target Oncol. 2020 Aug;15(4):449-466. doi: 10.1007/s11523-020-00738-6.
6
Immune Checkpoint Inhibitor-Mediated Diarrhea and Colitis: A Clinical Review.免疫检查点抑制剂介导的腹泻和结肠炎：一项临床综述。
JCO Oncol Pract. 2020 Aug;16(8):453-461. doi: 10.1200/OP.20.00002. Epub 2020 Jun 25.
7
Checkpoint Inhibitor-Induced Colitis.免疫检查点抑制剂相关性结肠炎
Am J Gastroenterol. 2020 Feb;115(2):202-210. doi: 10.14309/ajg.0000000000000497.
8
Cancer immunotherapy using checkpoint blockade.使用免疫检查点阻断的癌症免疫疗法。
Science. 2018 Mar 23;359(6382):1350-1355. doi: 10.1126/science.aar4060. Epub 2018 Mar 22.
Zotero 插件